Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida (terminated appraisal). NICE technology appraisal guidance 1154
National Institute for Health and Care Excellence (NICE)
Record ID 32018015681
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta1154
Year Published:
2026
URL for published report:
https://www.nice.org.uk/guidance/ta1154
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Urinary Bladder, Neurogenic
- Child
- Adolescent
- Adult
- Urinary Bladder, Overactive
- Urological Agents
- Mandelic Acids
- Muscarinic Antagonists
- Spinal Cord Injuries
- Spina Bifida Cystica
- Spina Bifida Occulta
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
3rd floor, 3 Piccadilly Place, Manchester, M1 3BN
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.